Figure 3. Carfilzomib potentiates the effects of CUDC-101 on cell cycle arrest in 8505c (A to D) and C-643 (E to H) cells.
Representative FACS data show that the combination of carfilzomib and CUDC-101 increase G2/M cell cycle arrest.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.